Publications
5600 Results
- Journal / Conference
- American Society of Hematology (December 5-8, 2020, San Diego, CA), oral, abst #388
- Year
- 2020
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106
Characteristics and Prognostic Effects of IDH Mutations across the Age Spectrum in AML: A Collaborative Analysis from COG, SWOG, and ECOG
- Journal / Conference
- San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), oral slide presentation, abst. GS402
- Year
- 2020
- Research Committee(s)
- Breast
- Study Number(s)
- CTSU/E2112
E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer. A trial of the ECOG-ACRIN Cancer Research Group
- Journal / Conference
- American Society of Hematology (December 5-8, 2020, virtual), poster presentation
- Year
- 2020
- Research Committee(s)
- Leukemia
- Study Number(s)
- S1203
Incidence and Prognostic Impact of Crh in Acute Myeloid Leukemia
- Journal / Conference
- American Society of Hematology (December 5-8, 2020, virtual), poster presentation
- Year
- 2020
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0816
Prognostication for Advanced Stage Hodgkin Lymphoma (HL) in the Modern Era: A Project from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium
- Journal / Conference
- American Society of Hematology (December 5-8, 2020, virtual), poster presentation
- Year
- 2020
- Research Committee(s)
- Lymphoma
Local Review versus (vs) Central Review of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Diffuse Large B-Cell Lymphoma (DLBCL): Results from the CALGB 50303 Trial [Alliance]
- Journal / Conference
- American Society of Hematology (December 5-8, 2020, virtual), poster presentation
- Year
- 2020
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S1826
SWOG S1826: A Phase III, Randomized Study of Nivolumab Plus AVD or Brentuximab Vedotin Plus AVD in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
- Journal / Conference
- American Society of Hematology (December 5-8, 2020, virtual), poster presentation
- Year
- 2020
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S1826
Evaluation of Activation of a National Cancer Trials Network (NCTN) trial for Hodgkin Lymphoma (HL) at Children’s Oncology Group (COG) Institutions
- Journal / Conference
- American Society of Hematology (December 5-8, 2020, San Diego, CA), TIPs, poster presentation
- Year
- 2020
- Research Committee(s)
- Myeloma
- Study Number(s)
- S1803
PHASE III STUDY OF DARATUMUMAB/rHuPH20 (NSC- 810307) + LENALIDOMIDE OR LENALIDOMIDE AS POST-AUTOLOGOUS STEM CELL TRANSPLANT MAINTENANCE THERAPY IN PATIENTS WITH MULTIPLE MYELOMA (MM) USING MINIMAL RESIDUAL DISEASE TO DIRECT THERAPY DURATION (DRAMMATIC STUDY): SWOG S1803
- Journal / Conference
- San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), COVID-19 Session, abst. SS2-05, poster
- Year
- 2020
- Research Committee(s)
- Breast
Emerging from COVID-19 pandemic: provider perspective on use of neoadjuvant endocrine therapy (NETI in early stage hormone receptor positive breast cancer
- Journal / Conference
- Society for Clinical Trials (virtual meeting September 1, 2020 - April 30, 2021), poster
- Year
- 2020
- Research Committee(s)
- Palliative Care
- Study Number(s)
- S1316